Christopher Burcham

Christopher Burcham Email and Phone Number

Professor of the Practice @ University of Illinois Urbana-Champaign
Indianapolis, IN, US
Christopher Burcham's Location
Indianapolis, Indiana, United States, United States
Christopher Burcham's Contact Details

Christopher Burcham work email

Christopher Burcham personal email

n/a
About Christopher Burcham

My career has been in process development working at the interface between formulated products and active ingredients, and building on my educational foundations of fluid mechanics, transport and interfacial science. My interest and experience with the development of formulated products started when I joined Corporate R&D at Dow Chemical, leading me to Dow AgroSciences. There I was involved with developing controlled release formulations through various batch and continuous encapsulation processes to produce nano- and micro-particles. The projects I developed spanned from new discovery formulations through to line extensions. Process and product design was accompanied with mechanistic models to predict release profiles and drive development.My initial responsibilities in the small molecule process development organization at Lilly were the development of the cGMP process steps for multiple active pharmaceutical ingredients. Since then I have commercialized multiple products, and have been involved in numerous other regulatory filings and technology transfer activities for projects at various stages of clinical development. In 2009, I formed and then served as the technical lead for our Particle Design Laboratory. The group is responsible for the development and technology transfer of crystallization processes for all small molecule active pharmaceutical ingredients currently in development. Crystallization is used to ensure product purity as well as to control particle size necessary to meet the needs of the downstream operations (filtration and drying), and to ensure patient performance (bio-availability).A large part of my responsibilities have been to introduce and grow technologies new to our organization - crystal engineering, spray dried dispersions, process modeling, and continuous crystallization, isolation and drying. To grow those technologies I have been had to grow and develop teams. I enjoy mentoring and coaching technical teams and always am amazed by what they have delivered in the end. My mentorship experience extends beyond the groups and projects that I have lead. I routinely mentor others across the company, and outside of Lilly. My future interests are to continue on a technical leadership track, growing my sphere of influence while simultaneously increasing my depth of knowledge. I am interested in organizations that value technical depth and have a strong interest in the utilization of modeling with clearly designed experiments to drive product development. International opportunities are of great interest as well.

Christopher Burcham's Current Company Details
University of Illinois Urbana-Champaign

University Of Illinois Urbana-Champaign

View
Professor of the Practice
Indianapolis, IN, US
Website:
fsi.illinois.edu
Employees:
229
Christopher Burcham Work Experience Details
  • University Of Illinois Urbana-Champaign
    Professor Of The Practice
    University Of Illinois Urbana-Champaign
    Indianapolis, In, Us
  • Eli Lilly And Company
    Executive Director Of Particle Engineering | Synthetic Molecule Design And Development (Smdd)
    Eli Lilly And Company Feb 2022 - Present
    Indianapolis, Indiana, United States
    Responsible for the development and scale-up of particle engineering and crystallization processes for all small molecule drug substances in development.Intercept projects after form selection. Continued with development through tech transfer and commercialization of the drug substance process.Tight integration and collaboration with the formulation analytical development groups to ensure that drug substance meets the requirements for new product formulations types and line… Show more Responsible for the development and scale-up of particle engineering and crystallization processes for all small molecule drug substances in development.Intercept projects after form selection. Continued with development through tech transfer and commercialization of the drug substance process.Tight integration and collaboration with the formulation analytical development groups to ensure that drug substance meets the requirements for new product formulations types and line extensions, includes physical property and purity control.Crystallization design, development and optimization for both batch and continuous processes.Accountable for all development activities for the commercialization of the drug substance synthetic process emphasizing the utilization of process modeling and a priori modeling tools to speed process development.Responsible for oversight and evolution of our absorption enabling strategy for poorly water-soluble compounds, primarily through the design and development of amorphous solid dispersions (ASD). Includes the internal and external process development of spray drying technology to produce ASDs and application of relevant modeling tools. Show less
  • Eli Lilly And Company
    Scientific Advisory Board Chair | Synthetic Molecule Design And Development (Smdd)
    Eli Lilly And Company Jun 2021 - Present
    Indianapolis, Indiana, United States
    Leading a team of scientist and engineers, responsible for the oversight of all external and internal innovation efforts within the department with an operating budget exceeding $MM.Developed a renewed innovation strategy for the department with a 10 year horizon.Reestablished SAB representation ensuring that all disciplines in the department were represented by the board, and established accountability of members.Lowered the barrier to entry for new and experienced… Show more Leading a team of scientist and engineers, responsible for the oversight of all external and internal innovation efforts within the department with an operating budget exceeding $MM.Developed a renewed innovation strategy for the department with a 10 year horizon.Reestablished SAB representation ensuring that all disciplines in the department were represented by the board, and established accountability of members.Lowered the barrier to entry for new and experienced scientists to consider external innovation through introduction of incubator sessions and discipline based mentoring relationships to build the next generation of innovators. Show less
  • Eli Lilly And Company
    Senior Engineering Advisor | Particle Design Lab Leader | Smdd
    Eli Lilly And Company Oct 2013 - Feb 2022
    Indianapolis, Indiana Area
    Active Pharmaceutical Ingredient (API) process design, development and optimization.Technology transfer from lab to pilot to production scale.Specialization in crystallization process development and amorphous solid dispersion development.Built spray drying capabilities from the ground up encompassing lab to commercial scale including online particle size analysis and laser Doppler anemometry.
  • Eli Lilly And Company
    Engineering Advisor | Particle Design Lab Leader | Smdd
    Eli Lilly And Company Oct 2010 - Oct 2013
    United States
    Created the group from its formation and designed efficient workflows for the development of the physical property control strategy for all small molecule APIs.Responsible for the development and scale-up of particle engineering and crystallization processes for all small molecule drug substances in development.Intercepted projects after successful Phase I clinical trial. Continued with development through tech transfer and commercialization of the drug substance… Show more Created the group from its formation and designed efficient workflows for the development of the physical property control strategy for all small molecule APIs.Responsible for the development and scale-up of particle engineering and crystallization processes for all small molecule drug substances in development.Intercepted projects after successful Phase I clinical trial. Continued with development through tech transfer and commercialization of the drug substance process.Tight integration and collaboration with the formulation and analytical development groups to ensure that drug substance meets the requirements for new product formulations types and line extensions, including physical property and purity control.Crystallization design, development and optimization for both batch and continuous processes.Introduced continuous crystallization, and isolation to the department. Strong utilization of population balance models to develop and optimize the continuous process.Developed the strategy to enable solubility and dissolution limited drug substances through utilization of solid amorphous dispersions and nano-particles formulations by established the capability within Lilly Show less
  • Eli Lilly And Company
    Associate Engineering Advisor | Scientific Team Leader And Group Leader | Smdd
    Eli Lilly And Company Oct 2005 - Oct 2010
    United States
    Responsible for the development and scale-up of compounds from Route Selection/Phase 1 through Commercialization. Process development leader and engineer for Effient™ (prasugrel HCl).o Developed and implemented (at Ube Industries) an improved and optimized drug substance. Development leader for semagacestat, an amyloid beta lowering compound (LY450139).o Scientific team leader for semagacestat. Responsible for the technical oversight of all CMC development activities… Show more Responsible for the development and scale-up of compounds from Route Selection/Phase 1 through Commercialization. Process development leader and engineer for Effient™ (prasugrel HCl).o Developed and implemented (at Ube Industries) an improved and optimized drug substance. Development leader for semagacestat, an amyloid beta lowering compound (LY450139).o Scientific team leader for semagacestat. Responsible for the technical oversight of all CMC development activities (analytical, formulated product, packaging and drug substance).o Led a cross functional team comprised of development analytical and process chemistry, development engineering, and manufacturing (all areas) in the optimization of the process.o Responsible for the technology transfer from pilot plant to commercial equipment and $MM campaign to support Phase III trials and registration stability and technology transfer to final commercialization site at Kinsale, Ireland and $MM campaign to support process validation, submission and launch.o Developed impurity control strategy for the drug substance, GMP intermediates and drug substance starting materials.o Developed a Design Space utilizing first principle kinetics models – a first for Lilly.o Developed and implemented PAT control in two of the GMP steps. Used to control the formation of difficult to purge impurity and to ensure proper form control of the drug substance.o Developed a crystallization process that utilized wet-milling and subsequent thermal cycling to reduce crystal aspect ratio from greater than 50:1 to less than 10:1. Result was substantial improvement of drug substance flow properties, allowing for the manufacture of the drug product utilizing a dry (roller compaction) process at a 35% drug load.o Patent granted on the crystal engineering process of the drug substance.o Interfaced closely with drug product development group during crystallization process development. Show less
  • Eli Lilly And Company
    Research Scientist/Sr. Research Scientist | Group Leader | Parenteral Technology Development
    Eli Lilly And Company May 2002 - Oct 2005
    Indianapolis, Indiana, United States
    Established the Parenteral Technology Development Group.Responsible for the development and implementation into Parenteral Manufacturing of various process improvements to minimize aseptic manipulations and connections in the manufacture of Humulin and Humalog products, reduced aseptic connections and manipulations by more than 60%.Optimization and understanding of protein (insulin) crystallization for Human Insulin.
  • University Of Strathclyde
    Visiting Professor
    University Of Strathclyde Aug 2022 - Present
    Glasgow, Scotland, United Kingdom
  • Dow Agrosciences
    Senior Research Engineer
    Dow Agrosciences Feb 1999 - May 2002
    Indianapolis, Indiana Area
    Formulations Research and Development. Formulation process optimization and technology transfer. Utilization of Nano and micro-encapsulation processes to control the release rates of pesticide formulations.
  • The Dow Chemical Company
    Research Engineer
    The Dow Chemical Company Feb 1998 - Feb 1999
    Midland, Michigan And Terneuzen, The Netherlands
    Central Research & Development. Interfacial Sciences, Engineering Plastics and Materials Research and Synthesis
  • Mobil Oil
    Chemical Engineering Intern
    Mobil Oil Jan 1992 - Aug 1992
    Dallas
    Development of technologies to extract crude oil from diatomaceous formations.
  • Mobil Oil
    Chemical Engineering Intern
    Mobil Oil May 1991 - Aug 1991
    Dallas
    To develop methods to extract heavy oil using tertiary recovery methods.
  • Pillsbury Co
    Chemical Engineering Intern
    Pillsbury Co May 1990 - Aug 1990
    Minneapolis
    Improving the quality of canned green beans through changes to the heating process.

Christopher Burcham Skills

Technology Transfer Chemical Engineering Process Simulation R&d Process Optimization Gmp Crystallization Process Engineering Chemistry Research And Development Validation Chromatography Hplc Quality By Design Formulation Design Of Experiments Biotechnology Organic Chemistry Laboratory Analytical Chemistry Pharmaceutical Industry Chemical Processing Fda Engineering Drug Development Matlab Pilot Plant Distillation Pharmaceutics Product Development Mathematical Modeling Science Life Sciences Research

Christopher Burcham Education Details

Frequently Asked Questions about Christopher Burcham

What company does Christopher Burcham work for?

Christopher Burcham works for University Of Illinois Urbana-Champaign

What is Christopher Burcham's role at the current company?

Christopher Burcham's current role is Professor of the Practice.

What is Christopher Burcham's email address?

Christopher Burcham's email address is cb****@****lly.com

What schools did Christopher Burcham attend?

Christopher Burcham attended Princeton University, University Of Illinois At Urbana-Champaign.

What skills is Christopher Burcham known for?

Christopher Burcham has skills like Technology Transfer, Chemical Engineering, Process Simulation, R&d, Process Optimization, Gmp, Crystallization, Process Engineering, Chemistry, Research And Development, Validation, Chromatography.

Not the Christopher Burcham you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.